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OBJECTIVES The goal of this study was to detect transplant arteriopathy (Tx-CHD) by a reduced
myocardial perfusion reserve (MPR) and resting endomyocardial/epimyocardial perfusion
ratio (Endo/Epi ratio).
BACKGROUND Transplant arteriopathy often lacks clinical symptoms and is the reason for frequent
surveillance angiography in heart transplant (Tx) recipients. Magnetic resonance perfusion
imaging (MRPI) allows noninvasive assessment of transmural and selective endomyocardial
and epimyocardial perfusion.
METHODS Fifteen healthy volunteers (controls) and three groups (A, B, C) of Tx recipients were
included. In controls and patients, MPR (hyperemic/resting perfusion) and Endo/Epi ratio
were determined with MRPI after injection of gadolinium-diethylenetriamine pentaacetic
acid at rest and during hyperemia (intravenous adenosine). Group A (n  10) had no left
ventricular (LV) hypertrophy and/or prior rejection, while patients in group B (n  10) had
at least one of these characteristics. Patients in group A and B had a normal coronary
angiogram and a coronary flow reserve (CFR) of 2.5 (CFR  hyperemic/resting blood
flow). Group C (n 7) had Tx-CHD diagnosed by angiography and a reduced CFR (2.5).
RESULTS In group C, MPR (1.7  0.5) and Endo/Epi ratio (1.1  0.2) were significantly reduced
compared with controls (4.2  0.7 and 1.6  0.3; both p  0.0001), group A (3.6  0.7 and
1.6 0.2; both p 0.0001) and B (2.7 0.9, p 0.01 and 1.4 0.1, p 0.04). Transplant
arteriopathy can be excluded by an MPR of 2.3 with sensitivity and specificity of 100% and
85%. If LV hypertrophy and prior rejection are excluded, Tx-CHD can be excluded by an
Endo/Epi ratio of 1.3 with 100% and 80%.
CONCLUSIONS Magnetic resonance perfusion imaging detects Tx-CHD by a decreased MPR. After
exclusion of LV hypertrophy and prior rejection, resting Endo/Epi ratio alone might be
sufficient to indicate Tx-CHD. (J Am Coll Cardiol 2003;42:1054–60) © 2003 by the
American College of Cardiology Foundation
With improved treatment for rejection, heart transplant
arteriopathy (Tx-CHD) has become the most important
factor affecting the survival after transplantation (1,2);
Tx-CHD is often asymptomatic. Frequent assessment of
the coronary circulation has been instituted to prevent
severe cardiac events in transplant (Tx) patients. Evaluation
of the coronary arteries solely by angiography is an insen-
sitive method in the detection of mild-to-moderate coro-
nary occlusive disease in Tx patients (3,4). Coronary flow
reserve (CFR) and intracoronary ultrasound have been used
to detect and assess the progression of Tx-CHD. However,
these techniques are invasive and require arterial access with
immobilization and a prolonged hospital stay with all the
increased risks and costs. Magnetic resonance perfusion
imaging (MRPI) using gadolinium-based contrast agents
has recently been validated as a versatile noninvasive clinical
tool to quantify myocardial perfusion (5). Using MRPI, it is
possible to quantify myocardial perfusion reserve (MPR)
(6). Myocardial perfusion reserve is a parameter that mirrors
CFR as a measure of the hemodynamic significance of
epicardial lesions in the respective perfusion territories.
In the present study we tested the hypothesis that
Tx-CHD characterized by a decreased CFR can be nonin-
vasively detected with MRPI in a heterogeneous group of
Tx patients. Due to its spatial resolution and good image
quality, MRPI allows not only determination of transmural
perfusion reserve but also allows selective assessment of
endomyocardial and epimyocardial perfusion (7,8). Because
there is evidence that the resting endomyocardial/
epimyocardial perfusion ratio (Endo/Epi ratio) decreases (9)
with impaired coronary circulation, we computed the Endo/
Epi ratio at rest to determine if a simple measurement of
myocardial perfusion at rest would be sufficient to detect
Tx-CHD.
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METHODS
Fifteen healthy volunteers (mean age 34  9 years; 10 men)
were assessed with MRPI to determine normal myocardial
perfusion. Afterwards, 27 heart Tx recipients (mean age
56  9 years; 20 men) were prospectively enrolled to
undergo MRPI after their annual invasive assessment. For
all subjects, written informed consent was acquired in
accordance with the requirements of the Institutional Re-
view Board for Protection of Human Subjects at the
University of Minnesota.
Patients underwent MRPI and a coronary angiogram,
including the assessment of CFR and a right ventricular
biopsy, all within 6 h. Patients and volunteers were asked to
refrain from caffeine intake 12 h before testing. Patients
discontinued beta-blockers 24 h and calcium-antagonists
12 h before testing. At the time of the study, all Tx
recipients were in stable clinical condition without signs of
heart failure (New York Heart Association class II or
ejection fraction 30%) or unstable angina. Acute or
ongoing rejection (International Society for Heart Trans-
plantation classification Ia [10]) was excluded in all
patients by histopathologic analysis of their myocardial
biopsy at the time of the study. Subjects who had contra-
indications for magnetic resonance imaging, such as metal
implants, were not enrolled.
Definition of groups. According to their post-Tx
follow-up evaluation (echocardiography, biopsy, angiogram,
and CFR), Tx recipients were separated into three groups.
Group A (n  10) included Tx recipients with no signs
of left ventricular (LV) hypertrophy on echocardiogram, no
episode of Tx rejection in their prior history, a normal
coronary angiogram (50% lumen obstruction determined
by quantitative coronary angiography), and a CFR of 2.5
determined by coronary Doppler flow measurement.
Patients in group B (n  10) differed from group A by
exhibiting myocardial hypertrophy (determined by an LV
wall thickness of 12 mm in the septum and posterior wall
on a standard short-axis echocardiogram) and/or a prior
episode of rejection requiring medical therapy. Left ventric-
ular hypertrophy was confirmed by measurement of LV
mass by magnetic resonance cine imaging. Patients in group
C (n  7) had Tx-CHD; Tx-CHD was defined as diffuse
concentric lumen narrowing (50%) in all three main
coronary arteries including the side branches, no eccentric
stenosis, and a CFR 2.5.
Invasive procedure and determination of CFR. Right
ventricular catheterization was performed via a femoral
access, and a myocardial biopsy specimen was obtained.
Thereafter, an arterial access was obtained, and sodium
heparin intravenous was given to prolong activated clotting
time to 300 s. After biplane selective coronary angiogra-
phy, a Flowire (0.014-inch, Cardiometrics, California) was
positioned via a 4F coronary catheter. The catheter position
was adjusted to obtain an adequate signal of coronary blood
flow velocity within the vessel. Mean arterial blood pressure
and heart rate were continuously monitored during the
procedure. Baseline measurement of coronary blood flow
velocity was obtained. Increasing boluses (2, 4, 8, 12, and up
to 16 g intracoronary) of adenosine (Adenoscan, Fujisawa,
Illinois) were administered through the coronary catheter
into the coronary ostium to reach maximal level of vasodi-
lation. Coronary flow reserve was determined by hyperemic/
resting blood flow velocity as described previously (11).
Magnetic resonance image acquisition. The imaging pro-
tocol was identical for Tx recipients and volunteers. A 1.5-T
magnetic resonance scanner (Siemens Vision, Erlangen,
Germany) and a phase-array body coil were used for
imaging. Scout images determined the short- and long-axis
view of the heart. Perfusion imaging during rest and
adenosine-induced hyperemia was then performed. Aden-
osine was titrated in three steps from 70 to 100 g/kg/min
to a maximum dose of 140 g/kg/min. Each dose was
administered approximately over 1 min. Image acquisition
was started 1 min after the start of the of the maximal
infusion rate. Total infusion time was approximately 3 min
plus the time required for image acquisition under 140
g/kg/min adenosine.
Perfusion was determined in three LV short-axis slices.
The first slice was located close to the base of the heart just
below the aortic outflow tract, the second in the middle of
the LV, and the third close to the apex just below the base
of the papillary muscles. A single shot gradient-echo se-
quence with saturation-recovery magnetization preparation
for T1 weighting and linear k-spacing was used for imaging.
The parameters were set to repetition time/echo time/flip
angle of 2.4 ms/1.2 ms/18° and a slice thickness of 10 mm.
Temporal resolution allowed acquisition of one image in
each of the three selected slices within one heart beat up to
a heart rate of 110 beats/min. Sixty images per slice location
were acquired with a spatial resolution of 2 to 3 mm.
Patients were asked to hold their breath at end expiration
for the first 15 to 20 s of each perfusion scan such that the
tracking of the first pass of the bolus at the three chosen slice
locations was not affected by respiratory motion. Three
heart beats after initiation of the sequence a compact bolus
of 0.03 mmol/kg bodyweight gadolinium-DTPA (Magne-
Abbreviations and Acronyms
AUC  area under the curve
CFR  coronary flow reserve (invasive)
CI  confidence interval
Endo/Epi ratio  resting endomyocardial/epimyocardial
perfusion ratio
ICUS  intracoronary ultrasound
LV  left ventricle/ventricular
MPR  myocardial perfusion reserve
(noninvasive)
MRPI  magnetic resonance perfusion imaging
RPP  rate-pressure product
SI  signal intensity
Tx  transplant
Tx-CHD  transplant arteriopathy
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vist, Berlex, New Jersey) was injected over an antecubital
vein at a rate of 7 ml/s using a power injector (MedRad,
Pennsylvania). Heart rate, peripheral blood pressure, and
O2 saturation were continuously monitored during the
magnetic resonance procedure. For best reproducibility we
transferred the geometric slice parameters (x-, y-, z-axis) of
the resting study to the hyperemic study using “copy slice
parameters” from the scanner menu. The rate-pressure
product (RPP) was calculated for rest and hyperemia at the
maximum rate of adenosine infusion.
For cine magnetic resonance imaging, an electrocardiogram-
gated, nonbreathold, segmented sequence was used with TR/
TE/flip angle 33 ms/6 ms/25°. Spatial resolution of the cine
sequence was 2  1.4 mm2 with a slice thickness and
increment of 10 mm. The temporal resolution was 30 to
50 ms, with 14 to 16 cardiac phases/plane. The whole LV was
imaged from base to apex.
Magnetic resonance image analysis. Image analysis was
performed blinded to the patient’s name, clinical status, and
results from the invasive measurements. Perfusion studies
were analyzed (ARGUS Software, Siemens, Iselin, New
Jersey) by manually applying endo- and epimyocardial
contours to the image with the brightest contrast enhance-
ment in the LV. An automated algorithm matched the
contours to the remaining images of the slice. Endomyo-
cardial and epimyocardial perfusion in the resting state were
assessed separately by applying the endomyocardial or
epimyocardial border and a midventricular line (“center-
line”) (Fig. 1). Spatially averaged signal intensity (SI) values
were used to plot SI curves over time of the whole
myocardial circumference and for a region of interest in the
center of the LV blood pool (input function). Model-
constrained deconvolution was used to calculate the maxi-
mum amplitude of the impulse response function from the
SI curves (12) using the input function measured in the LV
center. Based on the central volume theorem, the maximum
amplitude of the impulse response function measured in the
LV center can be interpreted as a measure of flow (13).
Myocardial perfusion reserve was calculated as the ratio of
the maximum amplitude of the impulse response function
for hyperemia and rest. This approach has been validated in
an animal model using radiolabeld microspheres (14). Myo-
cardial perfusion reserve and the CFR were normalized for
the RPP by the factor: mean group/individual RPP (15).
Figure 1. Perfusion analysis. (a) Four (of 50) images per slice showing the first pass of the contrast through the heart (picture 1  baseline image; picture
2  contrast in the right ventricle; picture 3  contrast in the left ventricle; picture 4  contrast in the myocardium). (b) Manual endomyocardial and
epimyocardial contour delineation, an automated algorithm matches the contours to the remaining images of the slice. (c) Signal intensity (SI) curves of
the contrast media through the left ventricle (LVin), the endomyocardium (endo) and epimyocardium (epi). Model-constrained deconvolution was used to
calculate the maximum amplitude of the impulse response function from the SI curves (12).
1056 Muehling et al. JACC Vol. 42, No. 6, 2003
Assessment of Tx-Myocardial Perfusion With MR September 17, 2003:1054–60
For cine analysis (MASS software, Leiden, the Nether-
lands [16]), determination of ejection fraction (%) and LV
myocardial mass, myocardial borders of the LV were de-
fined in each end-diastolic and end-systolic frame in con-
tiguous slices to create a three-dimensional set of data. Left
ventricular mass was normalized to the body surface area.
Statistics. Data were analyzed using SPSS (Release 10,
SPSS Inc., Chicago, Illinois). Analysis of variance was used
to test levels of significance. If significance was indicated by
analysis of variance, a Bonferonni correction was used as a
post-hoc test for multiple comparisons. Threshold values for
MPR and Endo/Epi ratios for the detection of Tx-CHD in
the Tx population were determined by receiver operating
characteristics and the area under the curve (AUC). All data
are mean  standard deviation. A value of p  0.05 was
considered significant.
RESULTS
Magnetic resonance image acquisition was successfully per-
formed in all volunteers and Tx recipients. All subjects
tolerated the procedure and contrast injection well. During
adenosine infusion some Tx recipients experienced short-
ness of breath (n 4), chest discomfort (n 4), or the urge
to breath deeply (n  2).
Demographic and hemodynamic data. The data are dis-
played in the Table 1. Volunteers were younger than Tx
recipients, but the age of the hearts were not different. No
significant difference was seen in age, ejection fraction, cold
ischemia time, or years after transplantation between the
three groups of Tx patients.
The resting heart rate in volunteers was significantly
lower compared with any of the Tx group. Therefore, the
RPPs in all Tx groups were significantly higher at rest
compared with volunteers. Heart rate increased during
adenosine infusion in volunteers but not in Tx patients.
Therefore, the RPP increased in volunteers during adeno-
sine infusion but not in Tx recipients. The ejection fraction
was significantly higher in volunteers than in any of the Tx
groups. Left ventricular mass in group B was significantly
higher compared with the other Tx groups or volunteers.
CFR, MPR, and Endo/Epi ratio. Coronary flow reserve
for group A, B, and C were 4.0  0.7, 3.2  0.7, and
1.9  0.9, with p  0.01 for B versus A and C and p 
0.0001 for C versus A and B. Data for MPR and Endo/Epi
ratios are shown in Figures 2 and 3. Coronary flow reserve
correlated significantly with MPR for group A (r  0.82,
r  0.01, y  0.97x  0.30), B (r  0.77, p  0.01, y 
0.74x  0.49), and C (r  0.73, p  0.01, y  0.84x 
0.05) and with Endo/Epi ratios for group A (r  0.74, p 
0.01, y  0.23x  0.68), B (r  0.72, p  0.01, y 
0.13x  1.04), and C (r  0.70, p  0.01, y  0.34x 
0.48) (Figs. 4A and 4B).
Table 1. Demographic Data and Hemodynamic Data During the MR Study
Volunteers Group A Group B Group C
Age (yrs) 34  9 57  13* 56  6* 56  3*
Male gender (%) 73 80 60 85
Years after Tx — 9  3 6  4 10  4
Tx organ age (yrs) — 35  8 34  11 42  11
Cold ischemia time (min) — 148  44 168  42 169  5
Ejection fraction (%) 65  3 59  4* 56  5* 51  11*
LV mass/BSA (g/m2) 91  8 94  11 118  9‡ 97  10
Heart rate (min1)
Rest 67  10 85  12* 87  5* 94  13*
Hyperemia 91  18† 85  12 87  3 88  5
Mean blood pressure (mm Hg)
Rest 95  8 98  10 102  9 94  11
Hyperemia 92  11 87  12 92  6 91  12
RPP (mm Hg/min)
Rest 6.3  1.0 8.4  1.5* 9.0  0.7* 9.0  1.6*
Hyperemia 8.5  2.5† 7.3  1.6 8.3  0.5 7.5  0.7
*p  0.001 vs. volunteers; †p  0.01 vs. rest; ‡p  0.01 vs. volunteers, A and C.
LV mass/BSA  left ventricular mass normalized to the body surface area; MR  magnetic resonance; RPP  rate-pressure
product; Tx  transplant.
Figure 2. Myocardial perfusion reserve in volunteers group A, B, and C of
the transplant recipients. *p  0.0001 versus volunteers; †p  0.0001
versus volunteers and A; ‡p  0.01 versus B; §p  0.03 between A and B.
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Using ROC analysis a cutoff value of MPR 2.3 for the
exclusion of Tx-CHD was determined with a sensitivity and
specificity of 100% and 85%. The positive predictive value
was only 63%, but the negative predictive value was 100%
(confidence interval [CI] 0.77 to 0.99; AUC 0.94). For the
Endo/Epi ratio, a cutoff value of 1.3 for the exclusion of
Tx-CHD was calculated by ROC analysis with only fair
sensitivity and specificity of 80% and 70% (positive and
negative predictive value: 40% and 93%; CI 0.58 to 0.93;
AUC 0.79). However, after exclusion of LV hypertrophy
and/or prior rejection, sensitivity and specificity rose to
100% and 80% using a cutoff value of1.3 for the exclusion
of Tx-CHD (positive and negative predictive value: 78%
and 100%; CI 0.76 to 0.98; AUC 0.97).
DISCUSSION
There are three important findings in our study:
1) Patients with Tx-CHD showed a reduced MPR and
resting Endo/Epi ratio; MPR of 2.3 excluded Tx-
CHD (negative predictive value 100%). Using only the
resting Endo/Epi ratio, we were able to exclude Tx-
CHD (negative predictive value 100%) when LV hyper-
trophy and/or prior rejection was excluded.
2) A significant correlation between invasive measurement
of CFR and the noninvasive evaluation of resting Endo/
Epi ratio using MRPI was shown, along with the known
significant correlation between CFR and MPR (5).
3) Myocardial perfusion reserve and Endo/Epi ratios are
normal in heart Tx recipients without myocardial hyper-
trophy, prior or acute rejection, or Tx-CHD. Transplant
recipients with a history of rejection or LV hypertrophy
even in the absence of clinical symptoms showed signif-
icant decrease in vasodialator reserve. These results are
consistent with the findings of McGinn et al. (17), who
showed normal coronary reserve in Tx recipients in the
absence of allograft rejection (18) and LV hypertrophy.
Coronary vasodialator reserve was diminished when LV
hypertrophy or rejection was present.
Using the Endo/Epi ratio and a cutoff value of 1.3,
healthy Tx recipients without LV hypertrophy or prior
rejection would not require further invasive or hyperemic
testing to exclude Tx-CHD. Hyperemic testing must be
considered in patients with LV hypertrophy or prior epi-
sodes of rejection for a more secure diagnosis of Tx-CHD.
Adding the information provided by hyperemic testing,
Figure 3. Endomyocardial/epimyocardial perfusion ratio in volunteers
group A, B, and C of the transplant recipients. *p  0.0001 versus
volunteers and A; †p  0.04 versus B.
Figure 4. Linear correlation of (A) coronary flow reserve (CFR) and
myocardial perfusion reserve (MPR) and (B) endomyocardial/
epimyocardial perfusion ratios (Endo/Epi ratios) and CFR in transplant
patients. Values in the right lower quadrant represent false positive for
transplant arteriopathy (Tx-CHD) as determined by the MPR (A) or
Endo/Epi ratios (B); values in the left upper quadrant represents false-
negative for Tx-CHD as determined by the MPR (A) or Endo/Epi ratio
(B). Cutoff values (dotted lines) for MPR (A) and Endo/Epi (B) ratios as
determined by receiver operating characteristic analysis (see text for
details). Circles  group A; squares  group B; triangles  group C of
the transplant patients.
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patients with an MPR of 2.3 could have been excluded
from further invasive testing.
Performing only a resting study would result in several
advantages. Besides the reduction in scan time, costs and
risks due to pharmacologic stress testing, hyperemic data
add a higher scatter to the values of quantitative perfusion
analysis (19). Despite a good sensitivity of hyperemic testing
for the detection of significant coronary artery disease,
hyperemic data results in a higher standard deviation (com-
pare standard deviation in Figs. 2 and 3) and might explain
the low positive predictive value of the MPR in this study
(63%).
Endo/Epi ratio. Healthy Tx recipients and volunteers have
the same level of Endo/Epi ratios, while patients with
Tx-CHD show a significant reduction in their Endo/Epi
ratios. A reduction in Endo/Epi ratio is likely to be related
to the reduced CFR, as seen in patients with Tx-CHD.
Two factors may explain the relationship between endo-
myocardial/epimyocardial perfusion and vasodilatory
capacity.
First, due to the closer proximity of the endomyocardial
layer to the LV cavity, there is a greater intramural pressure
in the endomyocardium compared with the epimyocardium.
This hampers the perfusion in the endomyocardium as
compared with the epimyocardium, and a reduction of
perfusion would be expected. However, an active reduction
in the coronary vascular tone in the endomyocardial layer
has been shown to result in a higher endomyocardial versus
epimyocardial perfusion. Subsequently, the Endo/Epi ratio
is 1 under resting conditions (20) as confirmed by our
data. Therefore, the endomyocardial layer will be more
sensitive to a compromised vasodilatory capacity because
part of the vasodilatory capacity has already been used.
Second, an increase in heart rate causes a decrease in the
Endo/Epi ratio (21,22). After cardiac Tx, resting heart rate
is increased. However, the Endo/Epi ratios in the healthy
Tx recipients (group A) of our groups were not different
from that in volunteers. Thus, Endo/Epi ratio in group A
most likely is sustained by partially recruiting the vasodila-
tory capacity in the endomyocardium.
Coronary reserve is compromised, and heart rate is
elevated in the group of patients with Tx-CHD. Conse-
quently, the Endo/Epi ratio decreases because endomyocar-
dial perfusion highly depends on an intact vasodilatory
capacity.
Study limitations. The small sample size is a limitation of
our study. However, even with the small samples, our results
were significant emphasizing the advantage of quantitative
magnetic resonance imaging.
All patients in group C were in an advanced stage of
Tx-CHD and had major abnormalities in their coronary
angiogram. Whether patients with mild disease would have
been clearly distinguished from healthy Tx recipients by
MR perfusion imaging cannot be determined. Studies using
intracoronary ultrasound (ICUS) are needed to test the
sensitivity of MRPI for detection of early stages of Tx-
CHD. A close relationship of the degree of intimal thick-
ening assessed by ICUS with abnormalities in coronary
function in Tx patients has already been demonstrated (23).
Although there is evidence for regional and segmental
heterogeneity in the endothelial response (24), MPR and
Endo/Epi ratios were not assessed regionally but over the
whole myocardial circumference. This might also explain
the good, but not perfect, correlation between MR perfu-
sion parameters and invasive CFR, which was only assessed
in the left anterior descending coronary artery. Assessing
regional differences is crucial in patients with coronary
artery disease. A segmentation of the myocardial circumfer-
ence in a different region is possible and has been performed
(6). In addition, we were only able to assess myocardial
perfusion in three slices. This was related to the high heart
rate in the Tx population. Using a higher temporal resolu-
tion would allow covering of more than three slices, but
would cause a loss in spatial resolution. Therefore, the
analysis of a transmural perfusion gradient would have been
cumbersome. Because Tx-CHD is a diffuse disease of the
LV myocardium, sensitivity to detect the disease was still
good using a three-slice coverage. In patients where perfu-
sion is regionally impaired, that is, in patients with coronary
artery disease, coverage of the whole LV myocardium would
be of great advantage. Good sensitivities and specificities for
the detection of coronary artery disease have been demon-
strated with magnetic resonance first pass imaging using a
four-slice approach (8).
Determination of endo- or epimyocardial perfusion in
patients with a thin LV wall, that is, after transmural
myocardial infarction or dilative cardiomyopathy, might be
cumbersome with the image resolution currently available.
However, the available resolution assesses a transmural
gradient of myocardial perfusion in subjects with normal or
increased LV wall thickness. In our subjects LV wall
thickness was7 mm, and resolution was2 mm in-plane.
Therefore, we did not face problems with transmural image
resolution.
Conclusions and clinical implications. Evaluation of
myocardial perfusion with MRPI was tested to detect
patients with Tx-CHD. Noninvasive determination of
myocardial perfusion reserve with magnetic resonance im-
aging allows exclusion of Tx-CHD and closely correlates
with the invasive data on coronary flow reserve. Further-
more, we were able to identify patients with Tx-CHD using
only the Endo/Epi ratio when LV hypertrophy and/or prior
rejection were excluded. In combination with the clinical
evaluation, MRPI might be an effective screening tool for
Tx-CHD. Using noninvasive MRPI for the annual
follow-up of Tx recipients might reduce the number of
patients needing invasive testing. In addition, in combina-
tion with magnetic resonance cine imaging for cardiac
function, MRPI might be a good method for routine
surveillance of patients after cardiac transplantation. The
present study demonstrates that perfusion can be reliably
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assessed by MRPI not only in patients with coronary artery
disease (6) or syndrome X (7) but also in heart Tx patients.
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